BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22869583)

  • 1. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality.
    Nagoshi H; Taki T; Hanamura I; Nitta M; Otsuki T; Nishida K; Okuda K; Sakamoto N; Kobayashi S; Yamamoto-Sugitani M; Tsutsumi Y; Kobayashi T; Matsumoto Y; Horiike S; Kuroda J; Taniwaki M
    Cancer Res; 2012 Oct; 72(19):4954-62. PubMed ID: 22869583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
    Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
    Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
    Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
    Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent advancements in molecular cytogenetics for hematological malignancies: identification of novel PVT1 fusion genes].
    Taniwaki M
    Rinsho Ketsueki; 2015 Oct; 56(10):2056-65. PubMed ID: 26458445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
    Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
    Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
    Ji M; Jang S; Lee JH; Seo EJ
    Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
    Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
    Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
    Guan Y; Kuo WL; Stilwell JL; Takano H; Lapuk AV; Fridlyand J; Mao JH; Yu M; Miller MA; Santos JL; Kalloger SE; Carlson JW; Ginzinger DG; Celniker SE; Mills GB; Huntsman DG; Gray JW
    Clin Cancer Res; 2007 Oct; 13(19):5745-55. PubMed ID: 17908964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma.
    O'Neal J; Gao F; Hassan A; Monahan R; Barrios S; Kilimann MW; Lee I; Chng WJ; Vij R; Tomasson MH
    Exp Hematol; 2009 Feb; 37(2):234-44. PubMed ID: 19135901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
    Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
    Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization.
    Rack KA; Delabesse E; Radford-Weiss I; Bourquelot P; Le Guyader G; Vekemans M; Macintyre EA
    Genes Chromosomes Cancer; 1998 Nov; 23(3):220-6. PubMed ID: 9790502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
    Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
    Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.
    Iida S; Hanamura I; Suzuki T; Kamiya T; Kato M; Hayami Y; Miura K; Harada S; Tsuboi K; Wakita A; Akano Y; Taniwaki M; Nitta M; Ueda R
    Int J Hematol; 2000 Jul; 72(1):85-91. PubMed ID: 10979215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
    Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
    Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel human myeloid leukemia cell line, AMU-AML1, carrying t(12;22)(p13;q11) without chimeric MN1-TEL and with high expression of MN1.
    Gotou M; Hanamura I; Nagoshi H; Wakabayashi M; Sakamoto N; Tsunekawa N; Horio T; Goto M; Mizuno S; Takahashi M; Suganuma K; Yamamoto H; Hiramatsu A; Watarai M; Shikami M; Imamura A; Mihara H; Taki T; Miwa H; Taniwaki M; Nitta M
    Genes Chromosomes Cancer; 2012 Jan; 51(1):42-53. PubMed ID: 21965128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
    Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
    Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.